Aviva’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$563K Sell
39,091
-13,964
-26% -$201K ﹤0.01% 685
2025
Q1
$366K Buy
+53,055
New +$366K ﹤0.01% 831